Structure and Functional Role of Bacterial CRISPR System

by A. V. Shashkova, A. A. Goryaev, N. I. Smirnova
Published 2011-04-01

Efficacy and Safety of Cholera Vaccines

by A. A. Goryaev, L. V. Sayapina, Yu. I. Obukhov, V. P. Bondarev
Published 2018-03-01

Studies of Immunobiological Properties in <i>Francisella tularensis</i> Vaccine Strain 15 NIIEG under Extended Storage Conditions

by L. V. Sayapina, E. A. Solov’Ev, A. A. Goryaev, V. P. Bondarev
Published 2015-06-01

Altered Variants of Cholera Agent Isolated in the Territory of the Russian Federation

by A. A. Goryaev, S. P. Zadnova, A. V. Shubina, Ya. M. Krasnov, N. I. Smirnova
Published 2011-02-01

Construction of an El Tor Biovariant Vibrio cholerae Strain Capable of Type II Cholera Toxin Hyperproduction and Determining the Optimal Conditions for the Production of This Prote...

by A. A. Goryaev, E. Yu. Shchelkanova, Yu. V. Lozovsky, I. V. Touchkov, N. I. Smirnova
Published 2008-02-01

<i>Vibrio cholerae</i> Genome Evolution: Ways of Atypical Strains Formation

by N. I. Smirnova, N. B. Cheldyshova, A. A. Goryaev, Yu. V. Lozovsky, V. V. Kutyrev
Published 2008-06-01

DNA and RNA Vaccines: Current Status, Quality Requirements and Specific Aspects of Preclinical Studies

by A. A. Goryaev, M. V. Savkina, Yu. I. Obukhov, V. A. Merkulov, Yu. V. Olefir
Published 2019-06-01

<i>Vibrio cholerae</i> O1 Avirulent Strains - Producers of Protective O1 Antigen: Obtaining and Peculiarities

by E. N. Strelnikova-Aab, L. F. Livanova, A. A. Goryaev, N. B. Cheldyshova, N. I. Smirnova
Published 2010-08-01

Live tularemia vaccine quality assessment according to test results under the mandatory certification

by I. V. Kasina, L. I. Raschepkin, A. A. Goryaev, S. A. Alekseeva, T. I. Nemirovskaya, A. A. Movsesyants
Published 2018-02-01

Construction of the PCR Test-System for the Detection of <i>Vibrio cholerae</i> O1 Toxigenic Strains, for Indication of Their Biovar and for Differentiation between Typical and Alt...

by A. V. Shashkova, A. A. Goryaev, S. P. Zadnova, Ya. M. Krasnov, N. I. Smirnova, V. V. Kutyrev
Published 2011-08-01

The Current Use of Biomedical Cell Products for Cancer Treatment

by E. A. Ustyugova, M. V. Savkina, A. A. Goryaev, V. P. Bondarev, V. A. Merkulov, E. V. Melnikova
Published 2019-12-01

Genome-Editing and Biomedical Cell Products: Current State, Safety and Efficacy

by A. A. Goryaev, M. V. Savkina, K. M. Mefed, V. P. Bondarev, V. A. Merkulov, V. V. Tarasov
Published 2018-09-01

Assessment of Residual Virulence of Francisella tularensis 15 NIIEG Vaccine Strain Based on Long-term Observations

by L. V. Sayapina, I. I. Khoreva, N. P. Baidalova, A. A. Goryaev, D. S. Davydov, V. P. Postupailo, V. A. Merkulov
Published 2018-04-01

Nucleotide Sequence and Phylogenetic Analysis of Glycoprotein-G of the Russian Fixed Rabies Virus Strain “Moscow 3253”

by I. V. Tuchkov, Ya. M. Krasnov, A. A. Goryaev, Zh. V. Matveeva, A. V. Stepanov, N. V. Mayorov, A. K. Nikiforov
Published 2013-12-01

International Approaches to Regulation of Medicinal Products Containing Viable Human Cells

by E. V. Melnikova, A. A. Goryaev, M. V. Savkina, O. V. Merkulova, A. A. Chaplenko, O. A. Rachinskaya, I. S. Semenova, G. A. Trusov, V. A. Merkulov
Published 2018-09-01

Certification and shelf-life extension of a new batch of the branch reference standard for live tularemic vaccine's specific activity and immunogenicity

by I. V. Kasina, A. A. Goryaev, L. I. Rashchepkin, O. V. Fadeykina, T. I. Nemirovskaya, O. B. Ustinnikova, O. A. Lobovikova, S. A. Alekseeva, R. A. Volkova, A. A. Movsesyants
Published 2018-02-01